Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$13.12 - $20.9 $874,946 - $1.39 Million
-66,688 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$28.97 - $48.21 $52,377 - $87,163
-1,808 Reduced 2.64%
66,688 $1.97 Million
Q1 2019

May 14, 2019

BUY
$36.32 - $49.25 $1.08 Million - $1.46 Million
29,726 Added 76.67%
68,496 $3.25 Million
Q3 2018

Nov 13, 2018

BUY
$56.15 - $73.9 $2.18 Million - $2.87 Million
38,770 New
38,770 $2.39 Million

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.